About Essenzaa Lifescience Limited
Data last updated:
Essenzaa Lifescience Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 February 2012.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36109MH2012PLC226651. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Probiotic Nutraceutical Limited. It is led by directors including Rajkumar Shamlal Jaiswal (Irp/Rp/Liquidator) and Manoj Balubhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 115 B – Wing Western Edge – 2 Western Express Highway Borivali (East), Mumbai, Maharashtra, India – 400066.
As per MCA filings, the company has open charges of ₹10.65 Cr on record.
The last known website on record is essenzaa.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address115 B – Wing Western Edge – 2 Western Express Highway Borivali (East), Mumbai, Maharashtra, India – 400066
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Essenzaa Lifescience Limited FY 2022 filings available
Essenzaa Lifescience Limited reported revenue of ₹3,860 (down 100% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Essenzaa Lifescience Limited
Revenue has declined at a compounded annual rate (CAGR) of 78% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Essenzaa Lifescience Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Essenzaa Lifescience Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Essenzaa Lifescience are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Essenzaa Lifescience Limited
Essenzaa Lifescience Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gastro Tech Private Limited | ₹4,660 (FY 2016) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Lakshmi Gurukul Engicon Private Limited | ₹4,480 (FY 2025) | •••• | •••• | •••• | Patna, Bihar, India | |
| Trumom Private Limited | ₹4,477 (FY 2025) | •••• | •••• | -81.0% | •••• | New Delhi, Delhi, India |
| VRG Biopharma Private Limited | ₹4,343 (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Smart Mediscience Private Limited | ₹4,110 (FY 2025) | •••• | •••• | -100.0% | •••• | Jaipur, Rajasthan, India |
| Essenzaa Lifescience Limited this company | ₹3,860 (FY 2022) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Perennial Marketing Services Private Limited | ₹3,755 (FY 2021) | •••• | •••• | -90.0% | •••• | Delhi, India |
| Baijnath Distributors Private Limited | ₹3,686 (FY 2025) | •••• | •••• | -84.0% | •••• | Patna, Bihar, India |
| Medimerz Pharma Private Limited | ₹3,503 (FY 2024) | •••• | •••• | -99.0% | •••• | Hyderabad, Telangana, India |
| Anv Pharmacy Private Limited | ₹3,405 (FY 2025) | •••• | •••• | 5.0% | •••• | Gurgaon, Haryana, India |
| J4serv Private Limited | ₹3,335 (FY 2024) | •••• | •••• | -100.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Essenzaa Lifescience by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Essenzaa Lifescience Limited
Essenzaa Lifescience Limited is audited by N P V & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N P V & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Essenzaa Lifescience Limited
Essenzaa Lifescience has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Shamlal Jaiswal | Irp/Rp/Liquidator | 29 Nov 2023 | 2 Years 10 Months | As last reported |
| Mayur Balubhai Shah Also directs: Maximaa Storage Systems LLP | Additional Director | 26 Oct 2020 | 5 Years 11 Months | As last reported |
| Manoj Balubhai Shah Also directs: Proyurveda Lifescience Private Limited | Director | 10 Feb 2012 | 14 Years 8 Months | As last reported |
| Arihant Nenawati Also directs: Truvisory Insolvency Professionals Private Limited | Irp/Rp/Liquidator | 21 Feb 2025 | 1 Years 7 Months | As last reported |
| Sneha Laxman Bhandare | Additional Director | 26 Oct 2020 | 5 Years 11 Months | As last reported |
Ownership and Shareholding of Essenzaa Lifescience Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Essenzaa Lifescience Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2016 | Bank of India | ₹5.81 Cr | Open |
| 19 Jan 2013 | Bank of India | ₹4.84 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Essenzaa Lifescience Limited
Employment history and EPFO contributions of people linked to Essenzaa Lifescience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Essenzaa Lifescience Limited
Essenzaa Lifescience Limited has 9 board changes on record since 2012: 5 appointments and 4 cessations. The latest: Arihant Nenawati was appointed as Irp/Rp/Liquidator on 21 Feb 2025.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Essenzaa Lifescience Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Essenzaa Lifescience Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Essenzaa Lifescience Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Essenzaa Lifescience Limited
Essenzaa Lifescience has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Essenzaa Lifescience Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Essenzaa Lifescience Limited
Essenzaa Lifescience is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Essenzaa Lifescience is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 February 2012 and is registered under CIN U36109MH2012PLC226651. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Essenzaa Lifescience has 5 current directors:
- Mayur Balubhai Shah - Additional Director
- Manoj Balubhai Shah - Director
- Sneha Laxman Bhandare - Additional Director
- Rajkumar Shamlal Jaiswal - Irp/Rp/Liquidator
- Arihant Nenawati - Irp/Rp/Liquidator
The CIN (Corporate Identification Number) of Essenzaa Lifescience is U36109MH2012PLC226651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Essenzaa Lifescience has open charges of ₹10.65 Cr and no satisfied charges on record as per latest MCA filings.
Essenzaa Lifescience was incorporated on 10 February 2012. It is registered with the Registrar of Companies, Mumbai.
The peers of Essenzaa Lifescience by revenue are Gastro Tech Private Limited, Lakshmi Gurukul Engicon Private Limited, Trumom Private Limited, VRG Biopharma Private Limited, Smart Mediscience Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Arihant Nenawati was appointed as Irp/Rp/Liquidator on 21 Feb 2025. Rajkumar Shamlal Jaiswal was appointed as Irp/Rp/Liquidator on 29 Nov 2023. Kunal Manojbhai Shah ceased to be Director on 31 Oct 2020. Essenzaa Lifescience has 9 board changes on record in total.
Essenzaa Lifescience can be reached through the website essenzaa.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Essenzaa Lifescience is at 115 B – Wing Western Edge – 2 Western Express Highway Borivali East, Mumbai, Maharashtra, India – 400066.
Essenzaa Lifescience has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr.